Alliance for Regenerative Medicine
Luca Alberici, Ph.D.,
Business Development Director
Milan, Italy


Previous video

Professor Mohamad Mohty (EBMT President) at the 58th Annual Meeting of the American Society of Hematology (ASH)

MolMed S.p.A. is a medical biotechnology company focused on research, development and clinical validation of innovative therapies to treat cancer.

Products of excellence

GMP Solutions

MolMed GMP Solutions provides tailor-made services for your cell & gene therapy projects.

Last presentation

Nov 29, 2016
Company presentation - November 29, 2016

Financial reports

Annual financial report (English translation for convenience) 2015
Interim financial report - in Italian, English translation to come at 09/30/2016
Half-year financial report -English translation for convenience at 06/30/2016
Interim financial report (English translation for convenience) at 03/31/2016

MolMed S.p.A. Via Olgettina, 58 - 20132 Milano, Italy | Phone +39 0221277.1 - Fax +39 02 21277.325 | -
Share capital € 21,514,284.36 fully paid - Office of Milan Company Registry number 1506630 - Tax identification number 11887610159